Philippinen - Englisch - FDA (Food And Drug Administration)

iae pharmaceuticals corporation; distributor: reach med pharma - cloxacillin (as sodium) - capsule - 500mg

Philippinen - Englisch - FDA (Food And Drug Administration)

iae pharmaceuticals corporation - vitamin b-complex - capsule - formulation: each capsule contains: thiamine mononitrate (vitamin b1)-300mg pyridoxine hydrochloride (vitamin b6)-150 mg ribofla

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; actinobacillus pleuropneumonie serovar 7; haemolysin toxoid; formaldehyde; thiomersal - misc. vaccines or anti sera - actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumonie serovar 7 vaccine-microbial active 0.0 units/ml; haemolysin toxoid vaccine-toxoid active 18.0 hu/ml; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - mycoplasma hyopneumoniae - inactivated antigen; thiomersal - parenteral liquid/solution/suspension - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 0.0 ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pig - adult - lung lesions | mycoplasma hyopneumoniae | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - isotonic medium not less than 18 hu/ml haemolysin toxoid; actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; formaldehyde; thiomersal - parenteral liquid/solution/suspension - isotonic medium not less than 18 hu/ml haemolysin toxoid ungrouped active 0.0 p; actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 p; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 p; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph | vaccine | equine rotavirus

Europäische Union - Englisch - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - a. pleuropneumoniae - vaccine

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - a. pleuropneumoniae - vaccine

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - mycoplasma hyopneumoniae - inactivated antigen - unknown - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 0.0 - active constituent

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski